Physician profile
Peter E Cornell
NPI 1235120866
$2,799.76
in general payments reported to CMS, 2019-2025
24 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.51 · 2022: $1,469 · 2023: $579 · 2024: $532 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253 · Entertainment: $17.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,252.92 |
| Entertainment | $17.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,200.00 | 2022 | |
| Paratek Pharmaceuticals, INC. | $248.28 | 2022-2025 | Nuzyra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $186.08 | 2022-2025 | Xifaxan |
| Lundbeck LLC | $145.83 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $139.85 | 2023-2024 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $136.12 | 2024 | Breztri, Farxiga |
| Kowa Pharmaceuticals America, INC. | $123.42 | 2023 | Livalo, Seglentis |
| Bayer Healthcare Pharmaceuticals INC. | $94.89 | 2023 | |
| Idorsia Pharmaceuticals US INC | $93.04 | 2023-2024 | Quviviq |
| Amgen INC. | $88.87 | 2023-2025 | Otezla, Repatha, Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $64.11 | 2022 | |
| Melinta Therapeutics, LLC | $38.00 | 2019 | |
| Stryker Corporation | $37.66 | 2025 | Ortholoc 3di, Anchorage |
| Aimmune Therapeutics, INC. | $34.76 | 2024-2025 | Zenpep |
| Abbvie INC. | $25.47 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $22.58 | 2024 | Cologuard Collection Kit |
| Azurity Pharmaceuticals, INC. | $18.25 | 2023 | Horizant |
| Otsuka America Pharmaceutical, INC. | $17.80 | 2023 | Rexulti |
| Optos, INC. | $17.18 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tactile Systems Technology INC | $16.43 | 2023 | Flexitouch Plus, Entre Plus |
| Nestle Healthcare Nutrition INC. | $15.26 | 2023 | |
| Advanced Oxygen Therapy INC. | $13.37 | 2025 | Topical Oxygen Chamber For Extremities |
| Merck Sharp & Dohme LLC | $11.40 | 2019 | |
| Horizon Therapeutics Plc | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Cornell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.